Chinese Journal of New Drugs and Clinical Remedies
|
2024, 43(8): 561-567
Expert consensus on grading criteria for adverse events of phase I clinical trials in healthy subjects
Full
Group for Expert Consensus on Grading Criteria for Adverse Events of Phase Clinical Trials in Healthy Subjects, Drug Clinical Trial Committee of Shanghai Pharmacological Society
Affiliations
Published: 2024-08-25
doi: 10.14109/j.cnki.xyylc.2024.08.01
Outline
Group for Expert Consensus on Grading Criteria for Adverse Events of Phase Clinical Trials in Healthy Subjects, Drug Clinical Trial Committee of Shanghai Pharmacological Society.
Expert consensus on grading criteria for adverse events of phase I clinical trials in healthy subjects[J].
Chinese Journal of New Drugs and Clinical Remedies,
2024
, 43
(8)
: 561
-567
.
DOI: 10.14109/j.cnki.xyylc.2024.08.01
Year 2024 volume 43 Issue 8
PDF
127
59
Cite this Article
BibTeX
Article Info
doi: 10.14109/j.cnki.xyylc.2024.08.01
- Receive Date:2024-04-09
- Online Date:2026-03-13
- Published:2024-08-25